We are pioneers in researching cancer vaccines and immunotherapy to improve patients' survival rates and their quality of life for a wide range of cancers.
We are very proud to announce that Ingenious Media has chosen us as their Charity of Year, 2018. Please see further information about is under out 'Tribute Funds' section.
We are dedicated to providing a tailored approach to all our patients giving them every possibility of a successful outcome.
One of the ways in which we are really unique is that we can direct our research interests so specifically. Each and every one of our scientists works on a research project which is informed in some way by Professor Dalgleish’s interests and the treatment he gives patients. Cancer patients are his inspiration, and the reason the ICVI exists.
If you have donated to ICVI in the past it is likely that you will receive our twice yearly newsletter. If you would prefer to no longer receive this newsletter please email email@example.com. If you would like a copy of the data that we hold for you please email firstname.lastname@example.org to request this. The ICVI never share details of our database to third parties and donations can be recorded anonymously on our database if requested, although this means that gift aid cannot be collected.
The ICVI held our third International Symposium on Immunotherapy in London in May 2017. Please have a look at our Summer 17 newsletter for more information about this event. You will also find a more technical report on this event in the newsletter section. We are hoping to hold a fourth Symposium in May 2019. If you would like to find out more about this please email email@example.com.
Make your online donation today by filling out the details provided below.